*ST Bio Co., Ltd.
*ST生物
000504
Shenzhen Stock Exchange
Key Financials
As of 2026-05-16T00:00:00.000+00:00Announcements
Nanhua Bio Progress Announcement on Application to Withdraw Delisting Risk Warning
Nanhua Biological 2025 Annual Board Audit Committee Performance Report
Nanhua Biological Announcement on 2025 Annual Uncovered Losses Exceeding One-Third of Paid-in Capital
Nanhua Biological Announcement on Adjusting Members of the Board's Special Committees
Nanhua Biological 2025 Annual Board Work Report
Nanhua Biological Three-Year Shareholder Return Plan (2026-2028)
Nanhua Biological 2025 Annual Goodwill Impairment Test Report
Nanhua Biological 2025 Annual Financial Settlement Report
2025 Audit Report of Nanhua Bio
Announcement on the 2026 Director Compensation Plan of Nanhua Bio
Announcement on the 2026 Senior Management Compensation Plan of Nanhua Bio
Independent Director's 2025 Annual Work Report of Nanhua Bio (She Liwen)
Independent Director's 2025 Annual Work Report of Nanhua Bio (Zhu Limei)
Independent Director's 2025 Annual Work Report of Nanhua Bio (Lin Feng)
Independent Director's 2025 Annual Work Report of Nanhua Bio (Zhao Yaqing - Resigned)
Nanhua Bio 2025 Internal Control Audit Report
Nanhua Bio 2025 Annual Internal Control Self-Evaluation Report
Nanhua Bio Director and Senior Management Compensation Management System
Announcement on Changes in Accounting Policies by Nanhua Bio
Announcement on the Provision for Credit Impairment, Asset Impairment, and Write-off of Certain Assets by Nanhua Bio for 2025
West Securities Co., Ltd. on the Summary Report of Continuous Supervision and Sponsorship for Nanhua Bio Pharmaceutical Co., Ltd. Issuing Stocks to Specific Objects
Special Report on the Annual Storage, Management, and Actual Use of Raised Funds for Nanhua Bio in 2025
West Securities Co., Ltd. on the Special Verification Opinion of the 2025 Annual Storage, Management, and Actual Use of Raised Funds of Nanhua Bio Pharmaceutical Co., Ltd.
West Securities Co., Ltd. on the Verification Opinion of the 2025 Annual Internal Control Self-Evaluation Report of Nanhua Bio Pharmaceutical Co., Ltd.
West Securities Co., Ltd. on the 2025 Annual Sponsorship Work Report of Nanhua Bio Pharmaceutical Co., Ltd.
Notice of the 2025 Annual Shareholders' Meeting of Nanhua Bio
Announcement of the Resolutions of the 9th Meeting of the 12th Board of Directors of Nanhua Bio
Announcement on the Proposed Non-Distribution of Profits for 2025 by Nanhua Bio
Verification Report on the Annual Storage, Management, and Actual Use of Raised Funds for Nanhua Bio in 2025
Special Verification Report on Non-Recurring Gains and Losses of Nanhua Bio
Special Audit Report on Revenue Deduction by Accounting Firm
Evaluation Report on the Performance of Nanhua Bio's Accounting Firm for 2025
Report on the Audit Committee's Oversight of the Accounting Firm's Performance in 2025
Special Audit Report on Non-Operational Fund Occupation and Other Related Fund Transactions of Nanhua Biological
Summary of Non-Operating Fund Occupation and Other Related Fund Transactions for Nanhua Bio in 2025
Special Opinion on the Independence Assessment of Independent Directors by the Board
2025 Annual Audit Report
2025 Annual Report
Summary of the 2025 Annual Report
Nanhua Biotech Announcement on Application to Withdraw Stock Delisting Risk Warning
Seventh Risk Warning Announcement on Possible Delisting of Nanhua Bio Stocks
Notes & Comments
Sign in to leave a comment or private note.
Loading…